ADCC activity of avidity variants. ADCC activity against Daudi cells using human PBMCs as effector cells at E/T ratio of 25:1. The ADCC activity of rituximab variants at various concentrations was measured using a standard LDH assay as described in “Cytotoxicity assays.” Data are mean ± SD (n = 3).